We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Cloud-Based Connectivity Platform Advances Decentralized Healthcare

By LabMedica International staff writers
Posted on 03 Aug 2016
A novel reporting platform enables real-time oversight, fragile network connectivity, and actionable insights for medical device manufacturers and healthcare providers.

The Fio (Toronto, Canada) Fionet platform connects mobile companion devices that guide diagnosis, treatment, and record keeping with web-based tools for remote oversight and reporting. More...
Fionet mobile software is designed for standard Android devices and the proprietary Deki Reader, a rugged, in vitro diagnostic (IVD) device for use with commercially available lateral flow immunoassays. As the Deki Reader provides step-by-step guidance for performing rapid diagnostic tests and delivers an objective analysis of results, Fionet provides test-by-test traceability.

As connectivity becomes an essential prerequisite for diagnostic platforms, Fionet meets the challenge by providing web-based tools for timely, accurate and complete record taking of individual patient visits; generating reports from aggregated, primary data; allowing two-way messaging with companion IVD devices; and easy data transfer and information technology (IT) integration. Fio will present the Fionet platform at AACC 2016.

“With healthcare services becoming more and more decentralized, device manufacturers are adapting their products from the lab outward. At Fio, we’ve built our data services from the field inward,” said Ian Fine, Chief Technology Officer of Fio. “Fio’s appearance at the AACC trade fair this year will provide an opportunity for the company to share insights from connecting diagnostics and data in developing countries.”

The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.

Related Links:
Fio
American Association for Clinical Chemistry


Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.